Research · head to head
Seven Bridges vs STARLIMS
Seven Bridges
Research
Cloud bioinformatics platform and trusted research environment, sold by Velsera
- From
- On request
- Rated
- -
STARLIMS
Research
Laboratory information management from Abbott for regulated and public health labs
- From
- On request
- Rated
- -
The short version
- Each has a real cost: Seven Bridges the parent merged into Velsera in 2023 alongside Pierian and UgenTec, so the platform now competes for roadmap attention with clinical interpretation and diagnostics products inside a private equity owned group.; STARLIMS implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
- They diverge on capability: Seven Bridges covers Trusted research environment, STARLIMS covers Sample and specimen management.
- Prices and features above were last checked on 31 August 2026.
Where they differ
Only the attributes on which Seven Bridges and STARLIMS actually diverge.
| Attribute | Seven Bridges | STARLIMS |
|---|---|---|
| Platforms | Web, API, Cloud | Web, Windows, Cloud, On-premise |
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Seven Bridges
- Trusted research environment
- Cloud-agnostic
- CWL pipelines
- Compliance certifications
- Cost prediction
- Public data commons
- Collaboration
- Tool library
Only in STARLIMS
- Sample and specimen management
- Quality management
- Instrument integration
- Public health reporting
- Regulatory compliance
- Web and mobile access
What people use each for
The jobs each tool is most often brought in to do.
Seven Bridges
- A cancer genomics group analysing controlled-access dbGaP data that cannot be moved to local infrastructurenot STARLIMS
- A federal or federally funded programme that needs FedRAMP Moderate authorisation for its analysis environmentnot STARLIMS
- A multi-institution consortium sharing pipelines and results under defined access controls rather than by emailing filesnot STARLIMS
- A diagnostics developer building reproducible CWL pipelines that must stand up to later regulatory reviewnot STARLIMS
STARLIMS
- Public health laboratories handling surveillance and outbreak investigationnot Seven Bridges
- Clinical laboratories needing regulated specimen tracking and reportingnot Seven Bridges
- Food safety and environmental testing laboratoriesnot Seven Bridges
- Multi-site laboratory networks standardising methods and specificationsnot Seven Bridges
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Seven Bridges
- The parent merged into Velsera in 2023 alongside Pierian and UgenTec, so the platform now competes for roadmap attention with clinical interpretation and diagnostics products inside a private equity owned group.
- Pricing is not published and splits into a platform subscription plus consumption-based cloud compute, so a heavy analysis quarter produces a bill that headcount-based budgeting does not anticipate.
- The analysis capability itself has credible open source equivalents in Nextflow and Cromwell on raw cloud, so you are principally paying for compliance and governance rather than for the science.
- Pipelines are built around Common Workflow Language, which is a real learning curve and a portability commitment for teams whose existing work is in other workflow languages.
- Cloud storage of large genomic datasets accrues continuously whether or not you are analysing, and egress charges apply when moving results out, both of which are outside the subscription line.
STARLIMS
- Implementation is lengthy and outcome quality depends heavily on the partner doing the configuration
- Pricing is quote-based with no public reference, making early budget setting difficult
- The breadth across laboratory types means some verticals get less development attention than others
- Interface modernisation has lagged behind newer cloud-native laboratory platforms
- Over-specified for small laboratories, where a lighter LIMS delivers most of the value for a fraction of the effort
Pricing, plan by plan
Seven Bridges
On request- Seven Bridges Platform$undefined/year
- Platform subscription quoted through Velsera sales
- Cloud compute and storage charged on consumption on top of the subscription
- Cost predictor tools provided to estimate analysis spend in advance
STARLIMS
On request- STARLIMS$undefined/year
- Sample management
- Quality management
- Instrument integration
Which should you pick?
Choose Seven Bridges if
- You need trusted research environment.
- You work on Web, API, Cloud.
- You also want cloud-agnostic.
Choose STARLIMS if
- You need sample and specimen management.
- You work on Web, Windows, Cloud, On-premise.
- You also want quality management.
Questions people ask
- Is Seven Bridges or STARLIMS better?
- Neither clearly leads. Seven Bridges starts at On request and STARLIMS at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Seven Bridges or STARLIMS?
- Seven Bridges starts at On request and STARLIMS at On request.
- Does Seven Bridges or STARLIMS run on more platforms?
- Seven Bridges runs on Web, API, Cloud. STARLIMS runs on Web, Windows, Cloud, On-premise.
- What is Seven Bridges best used for?
- Seven Bridges is most often used for a cancer genomics group analysing controlled-access dbgap data that cannot be moved to local infrastructure, a federal or federally funded programme that needs fedramp moderate authorisation for its analysis environment, a multi-institution consortium sharing pipelines and results under defined access controls rather than by emailing files, a diagnostics developer building reproducible cwl pipelines that must stand up to later regulatory review. Of those, a cancer genomics group analysing controlled-access dbgap data that cannot be moved to local infrastructure and a federal or federally funded programme that needs fedramp moderate authorisation for its analysis environment are not what STARLIMS is typically brought in for.
- What can Seven Bridges do that STARLIMS cannot?
- Seven Bridges covers Trusted research environment, Cloud-agnostic, CWL pipelines, Compliance certifications. STARLIMS covers Sample and specimen management, Quality management, Instrument integration, Public health reporting.
Answered from the vendors’ own pages
Seven Bridges: Is Seven Bridges still sold?
Yes. It is sold by Velsera, formed in 2023 when Summa Equity merged Seven Bridges with Pierian and UgenTec. The Seven Bridges name was retained for the platform.
STARLIMS: Who owns STARLIMS?
Abbott. That gives it institutional weight in laboratory procurement and a natural relationship with Abbott diagnostic instruments.
Seven Bridges: What compliance does it hold?
FedRAMP Moderate, SOC 2, HIPAA, GDPR, dbGaP and ISO 27001, 27017, 27018 and 27701, which is the usual reason institutions choose it over building on raw cloud.
STARLIMS: Where is it strongest?
Public health and clinical laboratories. Surveillance reporting, outbreak investigation and unpredictable specimen surges are different problems from pharmaceutical QC, and it handles them well.
Seven Bridges: How is it priced?
Not published. Expect a platform subscription plus consumption charges for cloud compute and storage.
STARLIMS: What does it cost?
Not published. Enterprise licensing plus implementation, quoted on laboratory count, users and modules.
Seven Bridges: Do I have to use a specific cloud?
No. The platform is cloud-agnostic and designed to bring analysis to where the data already resides.
STARLIMS: How does it compare to LabWare?
Both are enterprise LIMS with regulatory depth. LabWare is more dominant in pharmaceutical QC; STARLIMS has more presence in public health and clinical. Implementation partner quality matters more than the platform difference.
STARLIMS: What decides a successful implementation?
Configuration and validation quality, not platform features. Evaluations that compare feature lists rather than implementation approach are asking the wrong question.
Related pages
More on Seven Bridges
Other head to heads
- Seven Bridges vs DNAnexus
- Seven Bridges vs Terra
- Seven Bridges vs Dotmatics
- Seven Bridges vs Form Bio
- Seven Bridges vs Labguru
- Seven Bridges vs Chemaxon
- Seven Bridges vs Genedata
- Seven Bridges vs Greenphire
- Seven Bridges vs Medidata Rave
- Seven Bridges vs OpenEye, Cadence Molecular Sciences
- Seven Bridges vs Attest
- Seven Bridges vs NVivo
- Seven Bridges vs Schrodinger
- Seven Bridges vs Scispot
- Seven Bridges vs Suzy
- Seven Bridges vs TetraScience
- Seven Bridges vs Thermo SampleManager LIMS
- Seven Bridges vs LabWare
- Seven Bridges vs LabVantage
- Seven Bridges vs Benchling
- Seven Bridges vs Sapio Sciences
- Seven Bridges vs Roam Research
- Seven Bridges vs Contentsquare
- Seven Bridges vs Castor EDC
- Seven Bridges vs Valispace
- Seven Bridges vs Wolfram Mathematica
- STARLIMS vs DNAnexus
- STARLIMS vs Terra
- STARLIMS vs Dotmatics
- STARLIMS vs Form Bio
- STARLIMS vs Labguru
- STARLIMS vs Chemaxon
- STARLIMS vs Genedata
- STARLIMS vs Greenphire
- STARLIMS vs Medidata Rave
- STARLIMS vs OpenEye, Cadence Molecular Sciences
- STARLIMS vs Attest
- STARLIMS vs NVivo
- STARLIMS vs Schrodinger
- STARLIMS vs Scispot
- STARLIMS vs Suzy
- STARLIMS vs TetraScience
- STARLIMS vs Thermo SampleManager LIMS
- STARLIMS vs LabWare
- STARLIMS vs LabVantage
- STARLIMS vs Benchling
- STARLIMS vs Sapio Sciences
- STARLIMS vs Roam Research
- STARLIMS vs Contentsquare
- STARLIMS vs Castor EDC
- STARLIMS vs Valispace
- STARLIMS vs Wolfram Mathematica